Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NGNE
NGNE logo

NGNE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NGNE News

Neurogene Advances Gene Therapy for CNS Diseases

Apr 28 2026Newsfilter

Neurogene Reports FY GAAP EPS of -$4.24, Exceeding Expectations

Mar 24 2026seekingalpha

Neurogene Reports 2025 Financial Results and Updates

Mar 24 2026Newsfilter

NEUROGENE INC - FULL ENROLLMENT ACHIEVED AND OVER 50% DOSING IN EMBOLDEN TRIAL; EXPECTED TO FINISH DOSING BY Q2 2026

Mar 24 2026moomoo

NEUROGENE REPORTS FY NET INCOME OF -$90.351 MILLION

Mar 24 2026moomoo

NEUROGENE REPORTS FY OPERATING LOSS OF USD 103.328 MILLION

Mar 24 2026moomoo

Neurogene to Participate in Stifel 2026 Virtual CNS Forum

Mar 11 2026Newsfilter

Yatsen Holding Reports Q4 Earnings Decline

Mar 02 2026Benzinga

NGNE Events

04/20 07:40
Neurogene Appoints Christy Shafer as Chief Commercial Officer
Neurogene announced the appointment of Christy Shafer as Chief Commercial Officer and the appointment of Christine Mikail, president and CFO, to its Board of Directors. Shafer most recently served as Senior Vice President and General Manager, North America, of Avidity Biosciences.

NGNE Monitor News

No data

No data

NGNE Earnings Analysis

No Data

No Data

People Also Watch